From what I have read Li is a go getter and a builder all over the globe.
He is building a dynasty...........ABSOLUTELY HUGE.
Prof. Lugee Li Career History
Chairman/Founder Dongguan Eontec Co Ltd, PRESENT
Professor:Part Time Huazhong University of Science & Technology, PRESENT
Professor:Part Time Ningxia Inst of Sci & Tech, PRESENT
Distinguished ProfessorJiamusi University, PRESENT
Professor:Part TimeNanjing University of Science & Technology, PRESENT
ProfessorSouth China University of Technology, PRESENT
Li founded Eontec in 1993. He is also the founder and sole shareholder of Leader Biomedical Limited, a Hong Kong company involved in the advancement of biomaterials and surgical implants.
Medical is a potentially significant market for Liquidmetal. So are automotive and defense. Li serves as an analyst for the Institute of Metal Research at the Chinese Academy of Sciences and teaches at several universities in China.
Executed simultaneously with Li’s Purchase Agreement was the award of an exclusive license to Eontec for Liquidmetal development in China and the rest of Southeast Asia, including the Koreas and Thailand.
The stock purchase agreement is subject to the approval of a special meeting of Liquidmetal shareholders to be held before the end of May. Share prices rose almost immediately after the announcement from eight cents to 13 cents.
In the world of global economic growth and advancement of materials’ technologies, this is good news. Liquidmetal needed a deep-pocketed investor who believes in the technology and will invest in it.
Is this a technology with potentially significant military applications? I would feel comfortable if the U.S. government took a close look at the deal.
History Leader Biomedical
China Technology Media Li Yangde Founder
Prof. Lugee Li is the founder and sole shareholder of Leader Biomedical Group. Originally a materials engineer, Prof. Lugee Li is also the Founder and Chairman of Dongguan Eontec, a new materials company listed on the Shenzen Stock exchange.
Prof. Lugee Li currently heads China’s magnesium research initiate, which led him to team up with German companies to investigate the applications of magnesium in the medical field. It is this initiative that led to his entry into the field of medical devices.
2012: Foundation
Prof. Lugee Li recruits Leo Liyeung, Lili Yao, and Isaac Bresnick to help found Leader Biomedical.
2013: Acquisition of aap Joints
Prof. Lugee Li acquires a majority stake in aap Joints, the reconstructive implants division of aap Implantate in Berlin, Germany.
2014: Acquisition of EMCM and formation of Leader Biomedical Group
Having identified the synergies between biomaterials and surgical implants within the Chinese market, Prof. Lugee Li acquired EMCM, a biomaterials contract manufacturer, from aap Implantate. Subsequent to the acquisition, an organisation was established to support the future growth plans of the business with the appointment of Basil Babychan to the Board of Management and the establishment of Leader Biomedical’s HQ in Hong Kong, China, and Leader Biomedical Europe in Amsterdam, the Netherlands.
2015: Global expansion of Leader Biomedical Group
Leader Biomedical expanded its global footprint with the establishment of Leader Biomedical Brasil, in Sao Paulo, and Leader Biomedical India, in Bangalore.
The Board of Directors oversees the operations of Leader Biomedical and its subsidiaries.
Leo Liyeung, Executive Director
Leo Liyeung oversees corporate development, investments, as well as research and development for Leader Biomedical. He earned his Bachelor’s degree in Philosophy, Economics, and Mathematics in the United States.
Basil Babychan, Business Director
Basil Babychan manages the commercial operations of Leader Biomedical, including Marketing, Sales and Business Development. Basil has a degree in Biotechnology and an MBA. He has been part of Leader Biomedical and its predecessors since 2008.
Isaac Bresnick, Legal & Regulatory Affairs Director
Isaac Bresnick oversees Legal and Regulatory Affairs for Leader Biomedical. He has a Bachelors degree in Industrial Design and a Juris Doctor in Law, both completed in the United States. Isaac played a key role in founding Leader Biomedical and acquiring aap
Leader Biomedical has furthermore unveiled its own corporate identity and website.
The new corporate identity centres on the idea of “Extending your Reach” by increasing the access of next generation healthcare solutions to global markets, with an emphasis on high-growth emerging markets. Since the announcement of our strategy last year, Leader Biomedical has already started to deliver on this promise by setting up subsidiaries in India and China and consolidating its marketing and sales operations in Amsterdam, the Netherlands. Finally, it has also entered into a partnership with Dora Medikal to promote its proprietary eCOO® Technology in Turkey.
All these initiatives are in line with European Medical Contract Manufacturing or EMCM’s business strategy and will help it in its mission of becoming a centre for manufacturing excellence.
“Leader Biomedical was established to be a leading provider of biomaterials and medical implants with a strong footprint in high-growth markets, like China,” said Prof. Lugee Li, Founder and sole shareholder of Leader Biomedical.
“Through hard work and dedication, we’ve been able to move quickly and I am very pleased with the progress we have made. This is however only the beginning and you can expect more exciting news in the near future,” he continues.
Ultimately, Leader Biomedical’s ambition is to develop an integrated value chain encompassing new technological innovations, Manufacturing Operations (CMO & OEM), which will be EMCM’s main focus, and product marketing.
Leader Biomedical was founded by Prof. Li following the acquisitions of EMCM and aap Joints. The new corporate identity will bring these subsidiaries – along with future acquisitions – together under a single umbrella, uniting them through a common mission and vision.
The Apple-Liquidmetal deal is basically this: Apple contributes engineers and R&D – basically figuring out how to practically make Liquidmetal into commercial parts – and contributes their inventions back to Liquidmetal (via Crucible Intellectual Property, LLC, a Liquidmetal subsidiary) which gets to use Apple’s inventions in fields other than consumer electronics (sporting goods, aviation, medical, military, etc.). With an already-paid one-time license fee of US$20 million, Apple owns sole rights to use Liquidmetal in electronics forever via “a perpetual, worldwide,
fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products.” Every time we hear of Apple and Liquidmetal extending their agreement, it refers to Apple and Liquidmetal lengthening the amount of time where both companies share IP with
each other via Crucible.
